Skip to main content
. 2020 Jun;40(3):190–197. doi: 10.14639/0392-100X-N0311

Table V.

Locoregional recurrence rate among all patients studied (cases and controls) after a new risk stratification (ATA + Ki-67).

ATA + Ki-67 risk classification Locoregional recurrence (%)
Low risk Low ATA/Ki-67- 5/23 (21.7)
Intermediary risk Low ATA/Ki-67+
Intermediary ATA/Ki-67+ or -
High ATA/Ki-67-
34/58 (58.6)
High risk High ATA/Ki-67+ 3/3 (100.0)